Use Environment Analysis for Medical Devices: Assumptions Kill Adoption

By Ann Meyer with Jessica Willing-Pichs contributing

If you've ever worked on your own vehicle, you know the difference between a fully equipped shop and your home garage. Professional mechanics have hydraulic lifts, letting them stand upright with perfect access to every bolt. You? You're on your back on a cold driveway, contorting yourself around exhaust pipes with a rigid wrench that won't bend where you need it to. Same work. Completely different reality.

Medical device innovators face the same disconnect. Design in ideal conditions (clean labs, cooperative test subjects, ample space), then launch into messy clinical reality where assumptions shatter and workflows vary widely. Relatively small, regional medical centers do not have the space nor volume of team assets that academic medical centers or large hospitals in urban areas have. Community hospitals operate differently than flagship teaching institutions. Home care eliminates nearly all environmental controls.

Market projections erode. Adoption stalls. Reputation damage makes second pitches impossible. The culprit? Failure to perform rigorous, use environment assessment for the medical device. Not battle testing core assumptions in actual use environments before designs are frozen.

Five real-world examples show how preventable failures emerge when innovators skip use environment analysis and do not consider the physical, workflow, and human constraints of their intended environments, and why challenging those assumptions early changes everything.

When Assumptions Meet Reality: Five Failure Modes

These failures cluster into three patterns: space and mobility mismatches, storage and visibility issues, and form-factor paradigm shifts. Each reveal what happens when design teams stay in the lab or assume the use environment is a known entity.

Space and Mobility Mismatches

The ICU Infusion System That Forgot Patients Move

Design engineering team assumed that ICU patients stay in bed, stationary through therapy, and that additional fixed or nearly fixed bedside equipment would be acceptable.

Reality: Even critically ill patients are often moved out of the patient room. They need transport to imaging while on infusions, may be moved to a step down unit and are also encouraged to sit, stand, use the bathroom, and walk as they improve. ICU rooms already are packed with monitoring and therapeutic equipment. Another piece of fixed or movement-limited equipment substantially impedes clinician workflow and access to the patient.

The failure: systems designed for bedside-only use can't accommodate patient movement, and space constraints block care provision. The miss: never observing ICU workflow where beds, poles, pumps, patients and clinician work together.

The Surgical Robot That Couldn't Fit the OR

Equipment footprint assumptions came from academic medical centers with spacious operating rooms, validated only in large flagship hospitals.

Reality: A large surgical robotic system in small community hospitals consumed entire OR, forcing the hospital to dedicate the room to the system and only those procedures. The lack of physical flexibility limited the commercial revenue of that operating room.

The failure: space specifications did not meet community and rural hospital needs, killing significant market potential. The miss: not understanding the community setting.

Storage, Handling, and Visibility Issues

The Prescription Pill Bottle That Ignored Real Storage

Assumptions are always dangerous in MedTech innovations. For example, it is easy to assume that patients store medications in medicine cabinets and always read labels from the side.

Reality: Ethnographic research revealed medications living in kitchen baskets, by coffee makers, in purses, jumbled in drawers. When bottles rotate on shelves, labels disappear at critical moments.

The solution: redesign with a book-line spine label and top-down mark, visible however stored. The miss: never exploring actual home medication management environment behaviors because assumptions prevented teams from looking.

The Laminar Flow Hood Equipment That Has Potential to Create Contamination Risk

Design teams assumed compounding equipment placement wouldn't vary by user and spill management would work consistently.

Reality: Different pharmacy staff wanted equipment in different locations. When spills drained to the hood's back, staff may not see contamination, creating sterility risks in multi-user environments.

Failure: Perfect in single-user testing, a contamination hazard may arise when visibility determines safety. The miss: not observing multiple users across pharmacy settings.

Form-Factor Paradigm Shifts

The Capital-to-Portable Device That Changed Everything

Making a device portable seemed like an obvious value-add. More flexibility, easier adoption.

Reality: Portability introduced entirely new failure modes. Dropped devices. Lost equipment. Handling damage. For a preventative device, any barrier stops use. Reputation risk became untenable.

The win: caught during ethnographic research, project killed mid-stream, resources reallocated. The lesson: changed form factor equals changed use paradigm. Battle test from scratch.

Three Forces That Prevent Teams from Challenging Their Assumptions

Investor Pressure (Real or Perceived)

Timing demands for funding milestones create "move fast" culture that seems incompatible with field research.

The reality investors should know: formative testing and clinical utility research IS market assurance. Added time now means added market downstream, which expands the capital investment return.

Self-diagnostic: If your next funding milestone is forcing you to skip or skimp on formative assessments without real-world observation, that's a red flag for both you and your investors.

Tunnel Vision + Technology Obsession

The KOL Advisory Board trap: Academic centers have fellows and students doing "minutae prep work" that is often invisible or deprioritized by senior clinicians. When core surgical team members go on vacation, does the device still work? In regional and community hospitals, that full team never existed. Fewer hands, no checks and balances from day one.

Question for KOLs: "Could you do this alone at a community hospital in rural America with just a scrub tech (no fellows, no dedicated team)?"

Self-diagnostic: If your KOLs say it works but they're not doing the detailed prep work, you don't have full user validation.

Single Workflow Assumption

Inventor-clinicians assume all clinicians practice the same way. Early adopter needs don't equal majority user needs.

Self-diagnostic: If every sentence about workflow starts with "In my OR…" you're designing for an N=1 environment.

The Cost of Unchallenged Assumptions

These are the very real negative effects of assumptions gone untested:

Markets erode. Addressable commercial market shrinks significantly versus pitch deck projections.

Adoption suffers. Devices work in theory, but workflow, space, and handling constraints can prevent real-world uptake.

Reputations damage. You can't pitch the same customer twice. Word spreads in tight clinical communities.

Discoveries come late. Learning surprises at usability validation forces expensive redesign and downstream re-testing. Development timelines extend. Budgets balloon. Use environment analysis for medical devices surfaces these before they become exceedingly expensive or debilitating.

Regulatory complications multiply. Real-world risks that are identified late trigger new human factors testing requirements.

Capital gets wasted. Building the wrong thing well costs more than building the right thing from the start.

Home use multiplies these challenges. When patients become responsible for their own care with multiple tasks to accomplish (acquire, store, administer, monitor, etc.), environmental control disappears entirely. (See our article on The Market Shift to In-Home Care for more on this.)

What Investors Should Ask (And What Innovators Must Do)

For Investors Conducting Due Diligence

Challenge portfolio companies to defend their assumptions:

• "Show me formative research from at least three site types (academic, community, rural), not just your KOL's flagship hospital."

• "Walk me through use environment descriptions in the Design History File (DHF). Are there detailed specifics about space and workflow, or is the information generic?"

• "What surprised you during a contextual inquiry? If nothing, not enough assumptions have been challenged."

• "Show me how your use environment analysis guided your market model. If the model never changed after field research, what did you learn?"

• "How does your UFMEA/URRA reflect honest risk frequency from observations versus assumptions?"

Companies that can't answer with specifics are flying blind. Your capital is at risk.

For Innovators: Checkpoints for Challenging Assumptions

The critical "when" moments:

• Before DHF opens: Rough articulation of intended use environments and extremes in some detail with regional consideration (best-case and worst-case scenarios)

• Before design freeze: Multi-site contextual inquiry plus formative work with non-KOL users

• Before validation: At least one round of testing in equivalent real environments, not just pristine labs
  

Specific actions: 
Before DHF origination

• Conduct contextual inquiry at multiple sites representing market breadth (small/rural versus large/urban/academic)

• Document intended use environment(s) in detail. Treat it like scientific paper requirements with specific constraints

• Recruit formative testing users from outside your echo chamber

• Question every "should" and "typically." Those words hide unvalidated beliefs

During Design & Development

• Challenge assumptions at every stage gate, from initial market assessment through submission and manufacturing transfer

• Execute usability testing in equivalent use environments (even your living room reveals more than pristine test spaces)

• Scrutinize the rigor or the UFMEA/URRA with honest risk frequency from observation, not wishful thinking

Cross-portfolio integration: Human Factors validates devices in representative use environments with representative end users. Clinical Research ensures trial protocols reflect actual care settings; Commercial Strategy and Market Access confirm manufacturing scales to varied environmental demands.

Battle Testing the Use Environment Before Designs Harden - How Veranex Challenges Assumptions Before They Become Expensive Problems

Medical device development fails when teams build solutions disconnected from real clinical workflows, user needs, or market realities. Challenging assumptions early, before they calcify into design decisions, saves capital, protects timelines, and preserves market potential.

Veranex’s Research & Strategy, Human Centered Industrial Design and System Engineering teams leverage ethnographic research, competitive analysis, and stakeholder interviews at innovation's earliest stages, before concepts harden into designs that miss the mark. Our research team draws on Commercial Strategy and Market Access intelligence to ground discovery work in reimbursement realities and payer expectations. Field insights flow directly into Human Factors planning, Product Design & Engineering, and regulatory strategy. These insights translated to needs/requirements provide a solid foundation for product development.

Powered by the resources of an integrated “Innovation CRO,” the intelligence shaping your product concept travels with your program through design, evidence generation including preclinical studies and clinical trials when required, and launch. This accelerates your path to a device the market actually wants.

Ready to challenge your assumptions before they challenge your timeline? Get in touch.

About the author: Ann Meyer is Director of Systems Engineering for Veranex.

FAQ: Battle Testing the Use Environment

When is it too late to conduct use environment research?

It's almost never too late, but the later you wait, the more expensive fixes become. If you've frozen your design, you're late but not hopeless. Challenging assumptions at any stage saves money versus never challenging them. Best practice: start use environment analysis before the DHF is opened, continue through design validation. Even late discoveries prevent post-market adoption failures that can destroy reputation.

How many sites do I need to observe?

Minimum three representing market diversity. Typically, one academic/urban, one community/suburban, one rural/regional. More if use scenarios vary by specialty or patient population. The goal is breadth, not depth at a single site. One flagship hospital with your KOL gives less than acceptable, limited information about your addressable market.

What if my KOLs say the design works fine?

Not all KOLs are representative users. Many have background, interests, resources, support staff, and motivation most sites lack. Challenge the assumption that a KOL approval equals usability validation. It doesn't. Ask whether your device works when the backup team in charge, or when the night shift nurse (not the enthusiastic early adopter) is using it.

Does this apply to breakthrough innovations with no existing workflow?

Especially yes. You're asking users to adopt entirely new behavior in their existing environment with existing constraints. Understanding their current environment and challenging adoption assumptions is critical. Breakthrough innovations fail faster than incremental improvements when they ignore real-world constraints.

Work With Us

At Veranex, we don’t just map stakeholders and analyze systems in isolation. As part of the industry’s first integrated innovation CRO, we connect research insights directly to design, human factors engineering, engineering & product development, regulatory, clinical, and commercialization expertise under one roof. Because understanding the system is powerful, but having a partner who can act on that understanding across every discipline? That’s the difference.

Start a conversation about your innovation opportunity or challenge.